ATMI announces technology investment with Medinstill

Published: 24-Sep-2013
Manufacturing

Partnership to deliver sterile connector and fill technology


ATMI, a leader in single-use bioprocess solutions, has invested in sterile connector and sterile fill technology developed by Medical Instill Technologies (Medinstill), a developer of solutions for the transfer and packaging of high purity fluids at high safety levels.

The investment focuses on Medinstill's INTACT family of products, which will be deployed in sterile filling, sterile multiple-dose dispensing, sterile transfer, and packaging sterilisation solutions for the pharmaceutical, biotech, and healthcare industries.

'ATMI has a strong history of internal innovation as well as collaboration with other innovators,' said Doug Neugold, Chief Executive of ATMI.

'Collaboration with Medinstill is another great example of this strategy. Through this investment, we will develop a suite of products that address critical issues from our customers’ perspective as they continue to adopt single-use technology and other new inventions.'

'We are happy to partner with a company of ATMI’s stature,' added Daniel Py, Chairman of Medinstill. 'With its global reach and history of technical innovation in biopharmaceutical manufacturing, I believe ATMI can be instrumental in allowing us to bring products with the highest safety levels to those in need.'

INTACT Filler technology allows for sterile fill of multiple products into a broad range of containers and dosing devices in conditions significantly less stringent and less expensive than cleanrooms. ATMI and Medinstill have formed a joint venture to market and manufacture this technology, which is scalable from small lots in benchtop systems to industrial scales in the global biopharmaceutical and vaccine markets.

INTACT Connector technology will allow for sterile re-use of disposable connectors and ATMI has exclusively licensed this technology for the biopharmaceutical industry and will directly market the connector products once development is completed.

The firms say the INTACT connector technology will be the only multiple-use sterile connector to guarantee no contact between the liquid path and the external environment and ensures no ingress of air, bacteria, yeasts or mould.

  • Companies:
  • ATMI LifeSciences
See more

You may also like

Manufacturing

Opinion: Moving the goal posts

Read more
Suppliers of cleanroom technologies look set to benefit from the boom in biopharmaceuticals

Trending Articles

  1. APIs: Bioreactor hoists with a multipurpose twist Peter Devenny of PalPharma describes the solution for a biotech facility in Switzerland designed to handle filled bioreactors across GMP areas to produce ten metric tons of antibody per year
  2. Sigma-Aldrich appoints Darryl Goss as President of SAFC Hitech The company is a supplier of on-wafer materials to the microelectronics industry
  3. Isolator sterility put to the test Sterility testing must be carried out under strict aseptic conditions. Stacey Orley, Wickham Laboratories, describes the process to ensure products and devices are contaminant-free
  4. Handling potent drug materials Drug manufacturer Hovione has opened a new spray drying facility in Loures, Portugal, for potent active ingredients. Marco Marques, head of production, describes the safety protocols
  5. RABS, isolators and the track-and-trace trend Traditional aseptic production lines are a thing of the past. Isolators are being integrated with traceability systems to watch over safety of the product and the staff. Jorge Nuero of Telstar explains

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Opinion: Moving the goal posts

Suppliers of cleanroom technologies look set to benefit from the boom in biopharmaceuticals
Manufacturing

ATMI opens US laboratory for bioprocess application support

Company brings successful lab approach from Europe to provide comprehensive solutions to North American customers at Bloomington site
Manufacturing

ATMI and Finesse Solutions sign distribution agreement

Will allow both companies to offer seamless support for single-use bioreactor systems
Manufacturing

ATMI and Disposable-Lab introduce first single-use platform for fill/finish operations

Offers a smaller footprint and is fully disposable
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Gas storage with no added pressures

Hazardous, toxic gases used in semiconductor fabrication are stored in and delivered from high-density media that adsorb gas molecules inside nano-sized pore structures, virtually eliminating accidental gas releases. ATMI’s BrightBlack precision nanoporous carbon has been specifically optimised for pore size and density to achieve the most favourable physical adsorption of these dangerous gas molecules.
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Leak detection in process vessels

In the manufacture of biologicals single-use disposable flexible vessels are commonly used as bioreactors, mixers and sterile fill stations. To guarantee the vessels are of the quality needed to ensure process integrity, they must be proven free from biological contamination and free of leaks that could be an ingress route for contaminants such as bacteria. The traditional pressure decay method has significant limitations, so ATMI has created a reliable and repeatable method involving pressurising the vessel with helium instead of air. By using this method, defects as small as 10µm can be easily detected.
Manufacturing

ATMI announces Helium Integrity Testing

Detects leaks from holes as small as 10 microns in single-use bioprocess vessels
Subscribe now